Medytox Biopharma

Medytox is a leading South Korean biopharmaceutical company specializing in the development and manufacture of botulinum toxin products and hyaluronic acid fillers. Founded in 2000, the company became the first in Korea and the fourth in the world to develop a botulinum toxin type A product, marketed as Meditoxin (Siax/Neuronox). Medytox has since expanded its portfolio to include Innotox, the world's first liquid injectable botulinum toxin, and Coretox, a highly purified toxin free of animal-derived components. Beyond aesthetics, the company is diversifying into therapeutic areas such as oncology and inflammation through its R&D pipeline. Medytox maintains a significant global presence, exporting products to over 60 countries and operating state-of-the-art manufacturing facilities.